1. Home
  2. CELU vs HKIT Comparison

CELU vs HKIT Comparison

Compare CELU & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • HKIT
  • Stock Information
  • Founded
  • CELU 2016
  • HKIT 1996
  • Country
  • CELU United States
  • HKIT China
  • Employees
  • CELU N/A
  • HKIT N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • HKIT Computer Software: Prepackaged Software
  • Sector
  • CELU Health Care
  • HKIT Technology
  • Exchange
  • CELU Nasdaq
  • HKIT Nasdaq
  • Market Cap
  • CELU 42.2M
  • HKIT 39.8M
  • IPO Year
  • CELU N/A
  • HKIT 2023
  • Fundamental
  • Price
  • CELU $2.00
  • HKIT $1.37
  • Analyst Decision
  • CELU
  • HKIT
  • Analyst Count
  • CELU 0
  • HKIT 0
  • Target Price
  • CELU N/A
  • HKIT N/A
  • AVG Volume (30 Days)
  • CELU 75.7K
  • HKIT 10.3K
  • Earning Date
  • CELU 05-08-2025
  • HKIT 04-29-2025
  • Dividend Yield
  • CELU N/A
  • HKIT N/A
  • EPS Growth
  • CELU N/A
  • HKIT N/A
  • EPS
  • CELU N/A
  • HKIT N/A
  • Revenue
  • CELU $54,220,000.00
  • HKIT $2,904,950.00
  • Revenue This Year
  • CELU $23.29
  • HKIT N/A
  • Revenue Next Year
  • CELU N/A
  • HKIT N/A
  • P/E Ratio
  • CELU N/A
  • HKIT N/A
  • Revenue Growth
  • CELU 138.11
  • HKIT N/A
  • 52 Week Low
  • CELU $1.00
  • HKIT $1.15
  • 52 Week High
  • CELU $5.22
  • HKIT $1.86
  • Technical
  • Relative Strength Index (RSI)
  • CELU 51.94
  • HKIT 55.97
  • Support Level
  • CELU $1.80
  • HKIT $1.33
  • Resistance Level
  • CELU $2.26
  • HKIT $1.45
  • Average True Range (ATR)
  • CELU 0.18
  • HKIT 0.04
  • MACD
  • CELU 0.02
  • HKIT -0.00
  • Stochastic Oscillator
  • CELU 48.25
  • HKIT 64.29

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About HKIT Hitek Global Inc.

Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.

Share on Social Networks: